Scrip
28 January 2010
Nancy Faigen
A federal judge has handed
Teva Pharmaceutical Industries a win in ruling that
Merck & Co's US patent No 5,260,291 for the brain cancer drug Temodor (temozolomide) – the only Orange Book-listed patent – is unenforceable due to "prosecution laches and inequitable conduct",...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US FDA OK for Teva's generic Cozaar/Hyzaar, as authorised generic is announced
- Teva seeks to add more patents to US suit against Momenta/Sandoz on Copaxone
- Teva launches Yaz generic in the US, triggering patent infringement suit by Bayer
- Mylan sued over plans for Vytorin generic, and claims first-filer status
COMMENT
Other Informa Comment
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
